Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Diagnostics

Clarity is a clinical stage company developing products to address the growing need for the use of radiopharmaceuticals in oncology.

Pipeline - Developing Next-Generation Theranostics - Clarity

Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals - Products, Competitors, Financials, Employees, Headquarters Locations

Clarity and Cardinal Health enter into Agreement for Targeted Copper Theranostics

Clarity Completes Site Activation for SARTATE™ Clinical Trial for the Treatment of Meningioma - Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Imaging

The Evolving Landscape of Therapeutic and Diagnostic Radiopharmaceuticals - Xtalks

Clarity Pharmaceuticals on LinkedIn: First participant treated in the highest dose cohort of neuroblastoma…

BOP preliminary trial results presented at EANM 2023 conference - Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Imaging

Clarity Pharmaceuticals on LinkedIn: First participants imaged in SAR-Bombesin prostate cancer trial in…

Clarity bolsters antibody pre-targeting with IP from leading global cancer center - Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Imaging

ASX Health Stocks: Clarity Pharma shows effectiveness in diagnosing prostate lesions in Phase 1 trial - Stockhead

Clarity's theranostic prostate cancer trial advances to cohort 2

News - Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Imaging